Myasthenia gravis complicated with primary aldosteronism and hypokalemic myopathy. 2009

Shu-ichi Yamashita, and Wakaba Tsuchimochi, and Tadato Yonekawa, and Hideki Yamaguchi, and Itaru Kyoraku, and Kazutaka Shiomi, and Masamitsu Nakazato
Neurology, Respirology, Endocrinology and Metabolism, Dapartment of Internal Medicine, Faculty of Medicine, University of Miyazaki. syama@miyazaki-catv.ne.jp

A 34-year-old Japanese man was admitted to an outside hospital with an elevated creatinine kinase level and suspected myositis. He was treated with high dose methylprednisolone, which caused severe aggravation of muscle weakness. He was transferred to our hospital at that time. On admission, chest computed tomography (CT) and the presence of anti-acetylcholine receptor antibodies supported a diagnosis of myasthenia gravis and thymoma. Laboratory findings showed hypokalemia, low plasma renin activity and high serum aldosterone. Further studies, including abdominal CT and adrenal venous sampling suggested primary aldosteronism. At first, thymectomy was performed, and one month later, he was treated with laparoscopic adrenalectomy. Immediately after this procedure, he suffered from myasthenic crisis, which was successfully managed with mechanical ventilation and steroid pulse therapy followed by oral prednisolone. This case presented a serious difficulty in differentiating from various myopathies and giving proper treatment because of a rare combination of independent diseases and their masquerading clinical features.

UI MeSH Term Description Entries
D007008 Hypokalemia Abnormally low potassium concentration in the blood. It may result from potassium loss by renal secretion or by the gastrointestinal route, as by vomiting or diarrhea. It may be manifested clinically by neuromuscular disorders ranging from weakness to paralysis, by electrocardiographic abnormalities (depression of the T wave and elevation of the U wave), by renal disease, and by gastrointestinal disorders. (Dorland, 27th ed) Hypopotassemia,Hypokalemias,Hypopotassemias
D008297 Male Males
D009135 Muscular Diseases Acquired, familial, and congenital disorders of SKELETAL MUSCLE and SMOOTH MUSCLE. Muscle Disorders,Myopathies,Myopathic Conditions,Muscle Disorder,Muscular Disease,Myopathic Condition,Myopathy
D009157 Myasthenia Gravis A disorder of neuromuscular transmission characterized by fatigable weakness of cranial and skeletal muscles with elevated titers of ACETYLCHOLINE RECEPTORS or muscle-specific receptor tyrosine kinase (MuSK) autoantibodies. Clinical manifestations may include ocular muscle weakness (fluctuating, asymmetric, external ophthalmoplegia; diplopia; ptosis; and weakness of eye closure) and extraocular fatigable weakness of facial, bulbar, respiratory, and proximal limb muscles. The disease may remain limited to the ocular muscles (ocular myasthenia). THYMOMA is commonly associated with this condition. Anti-MuSK Myasthenia Gravis,MuSK MG,MuSK Myasthenia Gravis,Muscle-Specific Receptor Tyrosine Kinase Myasthenia Gravis,Muscle-Specific Tyrosine Kinase Antibody Positive Myasthenia Gravis,Myasthenia Gravis, Generalized,Myasthenia Gravis, Ocular,Anti MuSK Myasthenia Gravis,Generalized Myasthenia Gravis,Muscle Specific Receptor Tyrosine Kinase Myasthenia Gravis,Muscle Specific Tyrosine Kinase Antibody Positive Myasthenia Gravis,Myasthenia Gravis, Anti-MuSK,Myasthenia Gravis, MuSK,Ocular Myasthenia Gravis
D003937 Diagnosis, Differential Determination of which one of two or more diseases or conditions a patient is suffering from by systematically comparing and contrasting results of diagnostic measures. Diagnoses, Differential,Differential Diagnoses,Differential Diagnosis
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D006929 Hyperaldosteronism A condition caused by the overproduction of ALDOSTERONE. It is characterized by sodium retention and potassium excretion with resultant HYPERTENSION and HYPOKALEMIA. Aldosteronism,Conn Syndrome,Conn's Syndrome,Primary Hyperaldosteronism,Conns Syndrome,Hyperaldosteronism, Primary,Syndrome, Conn,Syndrome, Conn's
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

Shu-ichi Yamashita, and Wakaba Tsuchimochi, and Tadato Yonekawa, and Hideki Yamaguchi, and Itaru Kyoraku, and Kazutaka Shiomi, and Masamitsu Nakazato
November 1973, Rinsho shinkeigaku = Clinical neurology,
Shu-ichi Yamashita, and Wakaba Tsuchimochi, and Tadato Yonekawa, and Hideki Yamaguchi, and Itaru Kyoraku, and Kazutaka Shiomi, and Masamitsu Nakazato
December 1985, Endocrinologia japonica,
Shu-ichi Yamashita, and Wakaba Tsuchimochi, and Tadato Yonekawa, and Hideki Yamaguchi, and Itaru Kyoraku, and Kazutaka Shiomi, and Masamitsu Nakazato
December 2016, Experimental and therapeutic medicine,
Shu-ichi Yamashita, and Wakaba Tsuchimochi, and Tadato Yonekawa, and Hideki Yamaguchi, and Itaru Kyoraku, and Kazutaka Shiomi, and Masamitsu Nakazato
August 1978, Rinsho shinkeigaku = Clinical neurology,
Shu-ichi Yamashita, and Wakaba Tsuchimochi, and Tadato Yonekawa, and Hideki Yamaguchi, and Itaru Kyoraku, and Kazutaka Shiomi, and Masamitsu Nakazato
July 1992, Medicina clinica,
Shu-ichi Yamashita, and Wakaba Tsuchimochi, and Tadato Yonekawa, and Hideki Yamaguchi, and Itaru Kyoraku, and Kazutaka Shiomi, and Masamitsu Nakazato
May 2006, Journal of the Medical Association of Thailand = Chotmaihet thangphaet,
Shu-ichi Yamashita, and Wakaba Tsuchimochi, and Tadato Yonekawa, and Hideki Yamaguchi, and Itaru Kyoraku, and Kazutaka Shiomi, and Masamitsu Nakazato
May 2017, Journal of the neurological sciences,
Shu-ichi Yamashita, and Wakaba Tsuchimochi, and Tadato Yonekawa, and Hideki Yamaguchi, and Itaru Kyoraku, and Kazutaka Shiomi, and Masamitsu Nakazato
January 1970, Shinkei kenkyu no shimpo. Advances in neurological sciences,
Shu-ichi Yamashita, and Wakaba Tsuchimochi, and Tadato Yonekawa, and Hideki Yamaguchi, and Itaru Kyoraku, and Kazutaka Shiomi, and Masamitsu Nakazato
January 2012, Hormones (Athens, Greece),
Shu-ichi Yamashita, and Wakaba Tsuchimochi, and Tadato Yonekawa, and Hideki Yamaguchi, and Itaru Kyoraku, and Kazutaka Shiomi, and Masamitsu Nakazato
June 1998, Current opinion in neurology,
Copied contents to your clipboard!